Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of...

por Zheng, Sean L, Roddick, Alistair J, Ayis, Salma
Publicado 2017

The psychiatry virtual-on-call experience: Can it improve confidence of foundation and GP trainees with out-of-hours work in psychiatry?

por Harrison, Charlotte, Blamey, Helen, Roddick, Alistair, Saunders, Kate, Malhotra, Tina
Publicado 2021

Safety and pharmacokinetic profile of apixaban in end‐stage renal disease: A real‐world analysis

por Tseng, Chen I., Roddick, Alistair J., Bottomley, Matthew J., Shapiro, Susan, Udayaraj, Udaya
Publicado 2022

Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials

por Staplin, Natalie, Roddick, Alistair J., Emberson, Jonathan, Reith, Christina, Riding, Alex, Wonnacott, Alexa, Kuverji, Apexa, Bhandari, Sunil, Baigent, Colin, Haynes, Richard, Herrington, William G
Publicado 2021

UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE

por Roddick, Alistair J., Wonnacott, Alexa, Webb, David, Watt, Angela, Watson, Michael A., Staplin, Natalie, Riding, Alex, Lioudaki, Eirini, Kuverji, Apexa, Kossi, Mohsen El, Holmes, Patrick, Holloway, Matt, Fraser, Donald, Carvalho, Chris, Burton, James O., Bhandari, Sunil, Herrington, William G., Frankel, Andrew H.
Publicado 2023